A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Clinical trial NCT04895709 · RECRUITING

Trial details

NCT number: NCT04895709
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Gastric/Gastroesophageal Junction Adenocarcinoma Microsatellite Stable Colorectal Cancer Non-Small-Cell Lung Cancer Squamous Cell Carcinoma of Head and Neck Carcinoma, Renal Cell Urothelial Carcinoma Pancreatic Adenocarcinoma Melanoma Ovarian Neoplasms Triple Negative Breast Neoplasms

Start date: 2021-05-27
Primary completion: 2031-08-31
Enrollment: 1109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.